ASX:PRY

Mathan Somasundaram

Local market flip-flopped to finish as a positive day despite weaker China data. Tax loss selling in June will add to the seasonal weakness while better than expected retail data was mixed with weaker than expected China data. Market was buying into safety and weak currency stocks today. The best... Show More

Alex Cowie

In case reporting season kept you busy, we've summarised five top wires in February for you. Peter Quinton’s top ten picks for 2017, our fund manager earnings results review, and Buy Hold Sell with ‘Quality stocks on sale’ all deliver useful stock ideas. On big picture thinking, we bring you... Show More

Morgans Financial Limited

The healthcare sector has underperformed the broader market recently, but the fundamentals driving the sector remain the same. In the video below I discuss the healthcare stocks under Morgans coverage and provide a brief summary of our expectations leading into the 1H17 reporting season. Companies discussed include: ResMed, Cochlear, Sirtex... Show More

Bell Potter

In the report below, Head of Research Services, Peter Quinton, lists his top ten preferred stocks for calendar year 2017, with a brief synopsis on each one. Financials are well represented and Macquarie makes the list, with Peter describing it as “A global investment bank which is now facing a... Show More

Avatar fallback

Aside from Primary Health Care, today's note features smaller AGMs. First strikes at Australian Dairy Farms Group, Fleetwood Corporation, East Energy Resources and Quantum Energy and close at Carnarvon Petroleum. Not for the first time this season, I take a look at the show of hands or poll debate, using... Show More

Avatar fallback

You can find the main note at this link https://subscriber.theexecutiveremunerationreporter.com.au/archives/16303 and from there you can reach the other notes. ASX Listing Rule 10.17 resolutions to increase the non-executive director fee pool are one theme to look out for. I explain these resolutions in this note https://subscriber.theexecutiveremunerationreporter.com.au/archives/14158 and while many companies... Show More

Marcus Tuck

One theme we have explored in the past is the search for stocks that have a good combination of dividend yield and earnings growth, the so called GARY stocks (Growth And Reasonable Yield). We think that continues to be a sensible strategy and have screened the ASX 100 universe for... Show More

Bell Potter

Divisional EBIT: Medical Centres down 10.9% to $85.9m, Pathology up 5.9% to $134.9m, Imaging down 26.5% to $25.2m, Corporate down 7.6% to $49.7m | Net operating cash flow up 19% to $285.1m | Strategic transformation gaining momentum with the introduction of capital‐light healthcare practitioner recruitment packages, re‐focus on core activities... Show More